Concomitant use of Diclofenac sodium prolonged-launch tablets and cyclosporine might boost cyclosporine’s nephrotoxicity. A dosage adjustment could be warranted when diclofenac is administered with CYP2C9 inhibitors or inducers (see Medical PHARMACOLOGY; Pharmacokinetics). Like other selective COX-two inhibitors, diclofenac is contraindicated by having an FDA boxed warning in sufferer... https://aeschyluse812fgg4.activosblog.com/profile